AptarGroup, Inc. Form 10-Q Summary
Business Context and Reporting Period
This filing covers the quarterly period ended March 31, 1999. AptarGroup, Inc. is a manufacturer of pumps, metered dose aerosol valves, and dispensing closures for pharmaceutical, personal care, household, and food markets. The company operates globally, with significant exposure to European markets (France, Germany, Italy).
Key Financial Metrics
| Metric | Q1 1999 | Q1 1998 |
|---|---|---|
| Net Sales | $198.2 million | $170.9 million |
| Operating Income | $24.2 million | $22.5 million |
| Net Income | $14.3 million | $13.2 million |
| Diluted EPS | $0.39 | $0.36 |
| Operating Margin | 12.2% | 13.1% |
| Net Cash from Operations | $29.5 million | $16.8 million |
| Cash and Equivalents | $30.0 million | $25.2 million (Dec 31, 1998) |
| Net Debt to Capitalization | 35.7% | 18.3% (Dec 31, 1998) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 16.0% year-over-year. Approximately $22.7 million of the $27.3 million increase was attributable to acquisitions. A weaker U.S. dollar provided a positive translation effect; constant currency sales growth was 13.1%.
- Acquisition Impact: On February 17, 1999, the company acquired Emson Research, Inc. for approximately $123 million in cash and $4 million in stock, assuming $23 million in debt. This transaction significantly increased goodwill (by ~$80 million) and depreciation/amortization expenses.
- Expense Increases: Cost of sales as a percentage of net sales rose slightly to 62.6% due to overhead under-utilization in the fragrance market. SG&A expenses rose 16.6%, driven by acquisitions and Year 2000 (Y2K) readiness costs.
- Debt Structure: Interest expense increased 86.3% due to debt incurred for acquisitions. Short-term borrowings surged to fund the Emson purchase, though management intends to refinance portions into long-term obligations in Q2 1999.
Guidance, Outlook, and Risks
- Capital Expenditures: Management anticipates total capital expenditures for 1999 to be between $85 million and $90 million.
- Tax Rate: The effective tax rate for 1999 is expected to range between 35% and 36%.
- Seasonality: Results in the second half of the year are typically negatively impacted by European summer holidays and customer plant shutdowns in December.
- Year 2000 (Y2K) Risk: The company is in the renovation and testing phases of its Y2K program, with projected costs of $3.5 million. While no material disruption is currently anticipated from suppliers or customers, a worst-case scenario involving production facility interruptions could materially impact operations.
- Currency Risk: Significant exposure to European currencies (Eurozone). A strengthening U.S. dollar would have a dilutive effect on financial results.
Investor Verification Checklist
- Verify the integration progress and financial performance of the newly acquired Emson Research, Inc.
- Monitor the refinancing of short-term acquisition debt into long-term obligations as planned for Q2 1999.
- Assess the actual costs and timeline for Y2K compliance versus the $3.5 million estimate.
- Track the impact of the weaker U.S. dollar on future quarters if exchange rates normalize.
- Review the utilization of the $10 million remaining capacity under the revolving credit agreement.